Zdrowie i gospodarka · 13/05/2011
FDA Clears XIBROM (Bromfenac Ophthalmic Solution) 0.09% for Approval
The FDA has determined that XIBROM (bromfenac ophthalmic solution) 0.09% was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications.
Source: Federal Register — Health and Human ServicesOpen original release →